Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
404.58
-7.80 (-1.89%)
At close: May 9, 2025, 4:00 PM
406.69
+2.11 (0.52%)
After-hours: May 9, 2025, 7:35 PM EDT
Elevance Health Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$519.76
Upside
+28.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $478 | Buy | Reiterates | $478 | +18.15% | Apr 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $518 | Strong Buy | Reiterates | $518 | +28.03% | Apr 23, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $485 | Buy | Reiterates | $485 | +19.88% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $512 → $522 | Buy | Maintains | $512 → $522 | +29.02% | Apr 23, 2025 |
| Baird | Baird | Buy → Hold Downgrades $625 → $529 | Buy → Hold | Downgrades | $625 → $529 | +30.75% | Apr 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $480 → $510 | Strong Buy | Maintains | $480 → $510 | +26.06% | Apr 11, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $518 | Strong Buy | Initiates | $518 | +28.03% | Apr 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $455 → $505 | Buy | Maintains | $455 → $505 | +24.82% | Apr 9, 2025 |
| Argus Research | Argus Research | Hold Reiterates $405 | Hold | Reiterates | $405 | +0.20% | Jan 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $483 → $478 | Buy | Maintains | $483 → $478 | +18.15% | Jan 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $485 | Buy | Reiterates | $485 | +19.88% | Jan 24, 2025 |
| Barclays | Barclays | Buy Maintains $501 → $512 | Buy | Maintains | $501 → $512 | +26.55% | Jan 24, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $520 → $480 | Strong Buy | Maintains | $520 → $480 | +18.64% | Jan 6, 2025 |
| Mizuho | Mizuho | Buy Maintains $585 → $505 | Buy | Maintains | $585 → $505 | +24.82% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $593 → $495 | Buy | Maintains | $593 → $495 | +22.35% | Nov 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $643 → $551 | Buy | Maintains | $643 → $551 | +36.19% | Oct 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.